Gibb, A., Jones, C., Bloor, A., Kulkarni, S., Illidge, T., Linton, K. and Radford, J. (2013) “Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center”, Haematologica. Pavia, Italy, 98(4), pp. 611-614. doi: 10.3324/haematol.2012.069393.